心脏生物标志物在卒中和认知障碍中的作用
本专题综述评估了心脏生物标志物超越心血管健康的作用,聚焦其在卒中和痴呆中的重要性。第一部分描述卒中患者基于血液的心脏生物标志物在早期诊断、卒中后并发症、结局预测及二级预防中的应用;第二部分聚焦心脏生物标志物在血管性认知障碍和痴呆中的作用,强调其与结构性脑病变的关联。当前证据表明,基于血液、电生理和影像的心脏生物标志物可用于更好地理解卒中和痴呆情境下的心脑连接。
要点
- 利钠肽有助于鉴别卒中亚型,目前正在研究用于指导延长心电图监测和卒中二级预防。
- 缺血性卒中后心脏肌钙蛋白升高可提供卒中-心脏综合征相关并发症的信息。
- 心电图和超声心动图测量及血液生物标志物与血管性脑改变和痴呆发病呈一致关联。
核心结论
- 当前证据表明,基于血液、电生理和影像的心脏生物标志物可用于更好地理解卒中和痴呆情境下的心脑连接。
研究设计与样本
- 本专题综述评估心脏生物标志物在卒中和痴呆中的作用,第一部分描述卒中患者基于血液的心脏生物标志物应用,第二部分聚焦心脏生物标志物在血管性认知障碍和痴呆中的作用。
主要发现
- 利钠肽有助于鉴别卒中亚型,目前正在研究用于指导延长心电图监测和卒中二级预防。
- 缺血性卒中后心脏肌钙蛋白升高可提供卒中-心脏综合征相关并发症的信息。
- 沉默性脑梗死和白质高信号等结构性脑病变常与心脏病共存,可能是心血管疾病与后续认知下降之间的重要介质。
- 心电图和超声心动图测量及血液生物标志物与血管性脑改变和痴呆发病呈一致关联,提示其在指示认知下降风险中的作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This topical review assesses the growing role of cardiac biomarkers beyond cardiovascular health and focuses on their importance in stroke and dementia. The first part describes blood-based cardiac biomarkers in patients with stroke and highlights applications in the setting of early diagnosis, poststroke complications, outcome prediction as well as secondary prevention. Among other applications, natriuretic peptides can be helpful in differentiating stroke subtypes. They are also currently being investigated to guide prolonged ECG monitoring and secondary prevention in patients with stroke. Elevated cardiac troponin after ischemic stroke can provide information about various poststroke complications recently termed the stroke-heart syndrome. The second part focuses on the role of cardiac biomarkers in vascular cognitive impairment and dementia, emphasizing their association with structural brain lesions. These lesions such as silent brain infarcts and white matter hyperintensities often co-occur with cardiac disease and may be important mediators between cardiovascular disease and subsequent cognitive decline. ECG and echocardiogram measurements, in addition to blood-based biomarkers, show consistent associations with vascular brain changes and incident dementia, suggesting a role in indicating risk for cognitive decline. Together, the current evidence suggests that cardiac blood-based, electrophysiological, and imaging biomarkers can be used to better understand the heart and brain connection in the setting of not only stroke but also dementia.
引用
- Johansen MC, von Rennenberg R, Nolte CH, et al. Role of Cardiac Biomarkers in Stroke and Cognitive Impairment. Stroke. 2024. PMID: 39016019. doi:10.1161/STROKEAHA.123.044143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。